INTERNATIONAL PATENT: SOTIO BIOTECH A.S. FILES APPLICATION FOR "COMBINATION THERAPY INVOLVING ANTIBODY-DRUG CONJUGATES AGAINST CLAUDIN18.2 AND PD1/PD-L AXIS INHIBITORS FOR TREATMENT OF CANCER"

GENEVA, April 19 -- SOTIO BIOTECH A.S. (Ceskomoravska 2532/19b190 00 Prague) filed a patent application (PCT/EP2024/078871) for "COMBINATION THERAPY INVOLVING ANTIBODY-DRUG CONJUGATES AGAINST CLAUDIN18.2 AND PD1/PD-L AXIS INHIBITORS FOR TREATMENT OF CANCER" on Oct 14, 2024. With publication no. WO/2025/078686, the details related to the patent application was published on Apr 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): RASANEN, Kati (Bilmarkinkatu 4 as 2220100 Turku), PROCHAZKOVA, Ilona (K Beranovu 1181/9184 00 Prague 8), FOJTU, Michaela (76325 Vysoke Pole 82), KYRYCH SADILKOVA, Lenk...